Quality of Life in Patients with Recurrent Ovarian Cancer Treated with Niraparib Versus Placebo (ENGOT-OV16/NOVA): Results from a Double-Blind, Phase 3, Randomised Controlled TrialAmit M. Oza,Ursula A. Matulonis,Susanne Malander,Stacie Hudgens,Jalid Sehouli,Josep M. del Campo,Dominique Berton-Rigaud,Susana Banerjee,Giovanni Scambia,Jonathan S. Berek,Bente Lund,Anna V. Tinker,Felix Hilpert,Isabel Palacio Vazquez,Veronique D'Hondt,Benedict Benigno,Diane Provencher,Joseph Buscema,Shefali Agarwal,Mansoor R. MirzaLancet oncology/Lancet Oncology（2018）引用 109|浏览65暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
